CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01199055
Recruitment Status : Completed
First Posted : September 10, 2010
Last Update Posted : July 12, 2011
ICON Clinical Research
Information provided by:
Daiichi Sankyo, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2011
  Actual Study Completion Date : July 2011